Annual & Half Year Reports

2022

Interim Results for the six months ended 30 June 2022

2021

Annual Report & Account 2021 (inc. Notice of AGM)

Interim Results for the six months ended 30 June 2021

2020

Annual Report & Account 2020 (inc. Notice of AGM)

Interim Results for the six months ended 30 June 2020

2019

Annual Report & Account 2019 (inc. Notice of AGM)

Interim Results for the six months ended 30 June 2019

2018

Annual Report & Account 2018 (inc. Notice of AGM)

Interim Results for the six months ended 30 June 2018

2017

Annual Report & Account 2017 (inc. Notice of AGM)

Letter to shareholders re. electronic communications

reports

Latest News

FDA grants New Chemical Entity designation for XENOVIEW
01 February 2023

FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized)
28 December 2022
Update on New Drug Application
30 September 2022

About Us

Share Price

-

GBp

-

-

-

Annual Report & Account 2021 (inc. Notice of AGM)

Latest Annual Report

Important Dates

Important dates

29 Jun

Annual General Meeting

18 May

Final Results

Investor Alert

Sign up for Email Alerts